Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Braz J Microbiol ; 52(2): 749-759, 2021 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-33765286

RESUMO

Diclofenac (DCF) belongs to the class of nonsteroidal anti-inflammatory drugs, which is one of the most consumed by population and detected in raw sewage. Several studies have reported variable removal rates by biodegradation of diclofenac in wastewater treatment plants (WWTPs). This study deals with the evaluation of the biodegradation of DCF by a bacterial consortium (obtained from pure cultures of Enterobacter hormaechei D15 and Enterobacter cloacea D16), which were isolated from household compost and Algerian WWTP, respectively, as sole carbon source and by co-metabolism, using glucose as carbon source. A 98% removal rate of DCF was observed when it is used as the sole carbon source, whilst only 44% of DCF was removed in co-metabolic conditions. Two metabolites were identified using ultra-high-performance liquid chromatography coupled to electrospray injection tandem mass spectrometry analysis (UHPLC-ESI-MS/MS); one of them was identified as 4'-hydroxy-DCF, and the second metabolite was suspected to be a nitro derivative of DCF, according to comparison with the literature. Biodegradation of DCF by this bacterial consortium generates relatively safe final by-products.


Assuntos
Anti-Inflamatórios não Esteroides/metabolismo , Diclofenaco/metabolismo , Enterobacter cloacae/metabolismo , Enterobacter/metabolismo , Anti-Inflamatórios não Esteroides/química , Biodegradação Ambiental , Cromatografia Líquida de Alta Pressão , Diclofenaco/química , Enterobacter/genética , Enterobacter/isolamento & purificação , Enterobacter cloacae/genética , Enterobacter cloacae/isolamento & purificação , Glucose/metabolismo , Consórcios Microbianos , Microbiologia do Solo , Espectrometria de Massas em Tandem
2.
Braz J Microbiol ; 51(4): 1615-1622, 2020 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-32458261

RESUMO

In this study, we have investigated the effect of an antioxidant probiotic pretreatment toward an overdose of diclofenac in rats (100 mg/kg bw). Rats were treated daily with the probiotic Streptococcus salivarius St.sa (109 CFU) during seven successive days and then received a single treatment with diclofenac overdose in distilled water. Liver transaminases (alanine aminotransferase, aspartate aminotransferase, and alkaline phosphatase), histology, glutathione (GSH) and malondialdehyde (MDA) level were investigated. In addition, both antioxidant enzyme activity and its mRNA gene expression were studied to evaluate diclofenac hepatotoxicity. The results indicated that probiotic pretreatment reduced diclofenac-induced hepatotoxicity through enhancement of the studied hepatic markers and regulation of antioxidant enzyme expression and activity. These findings indicate that the probiotic pretreatment protects rat liver against the oxidative stress induced by diclofenac overdose.


Assuntos
Doença Hepática Induzida por Substâncias e Drogas/terapia , Fígado/efeitos dos fármacos , Estresse Oxidativo , Probióticos , Animais , Antioxidantes/metabolismo , Biomarcadores/metabolismo , Diclofenaco , Feminino , Peroxidação de Lipídeos , Fígado/patologia , Probióticos/uso terapêutico , Ratos , Ratos Wistar , Streptococcus salivarius
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA